{
  "id": 10456956,
  "title": "Merck licenses a KRAS G12D inhibitor for $400M upfront",
  "url": "https://urgent.news/2026/09/28/merck-licenses-a-kras-g12d-inhibitor-for-400m-upfront",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-28T14:00:16.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/merck-licenses-a-kras-g12d-inhibitor-for-400m-upfront/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Back in 2023, entrepreneur and synthetic chemist Tao Hu sold a KRAS G12D inhibitor to AstraZeneca. Today, he's selling another KRAS G12D inhibitor, this time to Merck — but with a twist that could make it ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}